MedTrace Logo

Bisphenol Role in the Pathogenesis of PCOS

NCT03436108 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2022-01-14

No results posted yet for this study

Summary

Polycystic ovary syndrome (PCOS) is the most common and the most heterogeneous endocrine disorder in premenopausal women. Its prevalence is estimated from 5 to 10% depending on the diagnosis' criteria .

Apart from signs of hyperandrogenism such as acne, hirsutism and hair loss; women with PCOS usually present with menstrual irregularities and fertility problems ..

Conditions

  • PCOS

Interventions

DIAGNOSTIC_TEST

Measurement of Bisphenol in urine

to see level of this material in blood of women

Sponsors & Collaborators

  • Kasr El Aini Hospital

    collaborator OTHER

  • Cairo University

    collaborator OTHER

  • Aljazeera Hospital

    lead OTHER

Principal Investigators

  • Mahmoud Alalfy · Algazeerah hospital -Location (Giza -Egypt )

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-10
Primary Completion
2019-12-01
Completion
2020-01-20

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03436108 on ClinicalTrials.gov